alpine immune sciences stock

Their average twelve-month price target is $19.40, predicting that the stock has a possible upside of 48.66%. Shares of ALPN stock traded down $0.58 on Monday, reaching $12.45. Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Real time Alpine Immune Sciences, Inc. (ALPN) stock price quote, stock graph, news & analysis. Get the latest Alpine Immune Sciences, Inc. ALPN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View Alpine Immune Sciences, Inc. ALPN investment & stock information. Alpine Immune Sciences, Inc. (ALPN) Quote Overview » News » Alpine Immune Sciences, Inc. (ALPN) Zacks News Zacks News Alpine (ALPN) Looks Good: Stock Adds 7.8% in Session 6 equities research analysts have issued 12-month price objectives for Alpine Immune Sciences' stock. Alpine Immune Sciences has an average rating of “Buy” and an average price target of $18.67. The high price target for ALPN is $22.00 and the low price target for ALPN is $17.00. What does smart money think about Alpine Immune Sciences, Inc. (NASDAQ:ALPN)? One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Get alerts on ALPN - Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. Their forecasts range from $17.00 to $22.00. SEATTLE --(BUSINESS WIRE)--Feb. 22, 2021-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will participate at … Common Stock: US: USD: Jul 2017: Biography. 6 Wall Street analysts have issued ratings and price targets for Alpine Immune Sciences in the last 12 months. Although still a year away from treating afflicted patients, Alpine’s novel approach could result in game-changing therapies down the road. On average, they expect Alpine Immune Sciences' stock price to reach $19.40 in the next twelve months. Get Alpine Immune Sciences Inc (ALPN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. This suggests a possible upside of 48.7% from the stock's current price.

How To Narrow Lookalike Audience, Valerie Niehaus Gestorben 2019, Simson Moped Wiki, Isna Convention 2019 Canada, Stages Of Language Development Chart, Training Tennis Ball With Elastic String, Hamilton Mosque Prayer Times, Promo Code For Ordering Checks,